ArticleBMC musculoskeletal disorders2012

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden.

Daniel R Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.